It aims to help women who have undergone an oncological process recover their self-esteem, satisfaction and the quality of life they might have lost due to the disease and treatments.

With minimally invasive surgery, a breast restoration is achieved that improves the aesthetic result reaching greater realism and naturalness.

Professionals from the services of Thoracic Surgery, General Surgery, Anaesthesiology and Intensive Care Medicine; from the Digestive Endoscopy Units of the Digestive System Service, and Respiratory, Pneumology and Nursing Services of the Bellvitge University Hospital (HUB) have participated in the extraction of an oesophageal prosthesis via the tracheal route, a complex procedure that was performed for the first time in the hospital last August.

The superconducting magnet of the PET/MRI equipment from the Bellvitge Hospital’s High Precision Diagnostic Centre has arrived this week at this centre, where it has already been installed in its final location. It is the main part of the PET/MRI equipment, together with the digital PET ring.

Bellvitge University Hospital and IDIBELL study has detected that the age at which the first symptoms appear has progressively increased from 1970 to 2019.

The Strack programme provides intensive patient follow-up during the first year after a stroke through remote monitoring and networking with primary care as well as patient empowerment tools.

More than 50 patients have joined the project, which aims to provide a comprehensive approach to the critical phase of the disease in order to reduce readmissions for cardiovascular pathology and unnecessary visits, while increasing adherence to treatment and physical and cognitive rehabilitation.

Multidisciplinary professionals from Bellvitge University Hospital, Viladecans Hospital and 17 Primary Care Centres in the Southern Metropolitan Area of the ICS work in a network. It is estimated that one in six people could suffer a stroke, making it the world’s main cause of disability and the leading cause of death in women.

Dapagliflozin significantly reduces the risk of cardiovascular death and hospitalisations for heart failure (HF). The study will lead to a change in HF treatment recommendations in international clinical guidelines, which will reinforce earlier use of the drug in patients.